PMCB
PharmaCyte Biotech, Inc. Common Stock
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
PharmaCyte Biotech (PMCB) Stock: Buy, Sell, or Hold?
$0.40
0.00 (-0.77%)
▼
5d:
+4.72%
30d:
+12.11%
90d:
-27.45%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (18%)
Quality Score
39/100
Position
EXTENDED
30-Day Fair Range
$0.33 – $0.39
Position: EXTENDED
Forward P/E & Valuation
7.0x
Next 12M consensus est.
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.25 / $0.43
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: PMCB shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When PMCB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: PMCB is currently trading at $0.40, which is considered extended relative to its 30-day fair value range of $0.33 to $0.39.
Technical Outlook: Technically, PMCB is in a strong downtrend. Immediate support is located at $0.25, while resistance sits at $0.43.
Market Sentiment: PMCB scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PMCB is in a strong downtrend. Immediate support is located at $0.25, while resistance sits at $0.43.
Market Sentiment: PMCB scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.33 -
$0.39
Company Quality Score
39/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
17.6%
Trading Range & Key Levels
30-Day Trading Range
$0.33 -
$0.39
Current vs Trading Range
EXTENDED
Support Level
$0.25
Resistance Level
$0.43
Current Trend
Strong Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (23/100)
- BULLISH: High volume confirmation
- WARNING: Composite score 39/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
7.02
Share PMCB Analysis
Share this live PMCB analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (PMCB)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 11, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits messages indicate bullish sentiment towards $PMCB with no specific details or catalysts mentioned.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 5:58 AM ET
Data refreshes hourly during market hours. Next update: 6:58 AM
Data refreshes hourly during market hours. Next update: 6:58 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PMCB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$107 | 61 BUY |
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$194 | 37 SELL |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
19 analysts |
$689 | 56 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$86 | 46 HOLD |
|
RCUS
Arcus Biosciences Inc |
STRONG BUY
15 analysts |
$41 | 63 BUY |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive PMCB Research Pages
